the benefits of glp-1 drugs beyond obesity glp 1 expanding role receptor agonists: a narrative review of current evidence and future directions GLP-1-based therapies for diabetes, obesity – WHO Backs Use Of GLP-1

The FDA concludes that more information is needed to determine potential harm

No universal Mounjaro settlements have been announced for all claimants

According to the World Health Organization, depression ranks among the leading causes of long-term disability, with its prevalence increasing annually

Their major limitation is a lack of control over nutrients and gas exchange and waste disposal, which was overcome in microfluidic liver-on-chip platforms enabling automated control over these factors

These are neurodegenerative diseases, which besides optic nerve and spinal cord also affect the brain parenchyma and cause neurological and cognitive presentations

Diets with low levels of protein and iron can also result in low vitamin B12 levels